Antonella Capasso

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Challenges in liver stiffness measurement: cardiovascular complications as diagnostic pitfalls in sinusoidal obstruction syndrome.

Challenges in liver stiffness measurement: cardiovascular complications as diagnostic pitfalls in sinusoidal obstruction syndrome.

Journal: Bone marrow transplantation

Published: March 14, 2025

Validation of Manhattan risk to predict aGvHD severity in Rapamycin and PTCy-based prophylaxis: a study on 459 consecutive HCT patients.

Validation of Manhattan risk to predict aGvHD severity in Rapamycin and PTCy-based prophylaxis: a study on 459 consecutive HCT patients.

Journal: Bone marrow transplantation

Published: March 03, 2025

Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL.

Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL.

Journal: American journal of hematology

Published: October 05, 2023

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.

Journal: American journal of hematology

Published: June 25, 2023

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib.

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib.

Journal: Blood advances

Published: August 24, 2022

Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL.

Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL.

Journal: Blood

Published: May 10, 2022

Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL.

Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL.

Journal: Journal of hematology & oncology

Published: April 19, 2022

Are we finally getting personal? Moving towards a personalized approach in chronic lymphocytic leukemia.

Are we finally getting personal? Moving towards a personalized approach in chronic lymphocytic leukemia.

Journal: Seminars in cancer biology

Published: October 22, 2021

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.

Journal: Leukemia

Published: July 28, 2021

Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach?

Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach?

Journal: European journal of internal medicine

Published: July 13, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026